Clinical trial
Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control
NCT02025465 is registered in ClinicalTrials.gov with CAMC Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control
- Lead sponsor
- CAMC Health System
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- December 31, 2013
- Completion date
- May 30, 2024
- Enrollment
- 69 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.